![]() |
![]() Program AdvisorsDavid Adler, PharmD Captain Linnea M. Axman, Nurse Corps, United States Navy, Ph.D., MSN, CFNP, FAANP Darrel P. Cohen, M.D., Ph.D. Senior Director, Oncology Clinical Development; Pfizer Global Research and Development La Jolla Gary S. Firestein, M.D. David Frakes, M.D., FRCPC, FAPA Gabriel G. Haddad, M.D. Robert J. Hye, M.D. SCPMG, Kaiser Permanente, San Diego Carolyn Kelly, M.D. Orville Kolterman, M.D. Ted Okerson, M.D., MAS CLRE, FACP Executive Director, Clinical Research, Amylin Pharmaceuticals, Inc. Norman A. Paradis, M.D. Vice President and Chief Medical Officer, Cylex Inc. Robert E. Parson, M.S., MAS LHCO, CRE, CQE, CHE Vice President, Global Clinical/Regulatory Affairs, Inverness Medical Innovations, Biosite Inc. Mitchel Reff, Ph.D. Vice President, Discovery Oncology, Biogen Idec, Inc. Captain Jacqueline D. Rychnovsky, Nurse Corps, United States Navy, Ph.D., MSN, BSN Senior Nurse Executive for the Director of Professional Education and Head Nursing Research and Analysis at the Naval Medical Center, San Diego Joseph E. Scherger, M.D. Professor of Clinical Medicine, UCSD School of Medicine, San Diego County Medical Society Kobi M. Sethna President and Chief Executive Officer, Nereus Pharmaceuticals Christian Weyer, M.D., MAS CLRE Executive Director, Clinical Research, Amylin Pharmaceuticals, Inc.
|
|
|